ConductScience.org, home

Paper28711

"Akinetic depression" in schizophrenia.

Van Putten T and 1 other. Arch Gen Psychiatry, 1978. Cited by 294 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. "Akinetic depression" in schizophrenia. Papers, record 28711. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28711

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
"Akinetic depression" in schizophrenia.
PubMed
Journal
Arch Gen Psychiatry
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
294
iCite
Relative citation ratio, by iCite
16.2
iCite
Revised in PubMed
2022-03-18
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Van Putten TT
2May RPR P

Source PubMed

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antipsychotic AgentsMajor topic
DepressionMajor topic
SchizophreniaMajor topic
Humans
Sleep Stages

Source PubMed

Cited by44

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 294 citations.

PMIDTitleJournalYearIn PapersSource
39,006,901Diagnosis and treatment depression in schizophrenia.Consort Psychiatr2020https://conductscience.org/library/papers/39006901PubMed
37,083,542Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders: A Secondary Outcome Analysis of a Pragmatic, Randomized Trial (BeSt InTro).J Clin Psychopharmacol2023https://conductscience.org/library/papers/37083542PubMed
36,624,935Longitudinal effect of clozapine-associated sedation on motivation in schizophrenia: naturalistic longitudinal study.Br J Psychiatry2023https://conductscience.org/library/papers/36624935PubMed
33,151,310Antidepressive Effect of Antipsychotics in the Treatment of Schizophrenia: Meta-Regression Analysis of Randomized Placebo-Controlled Trials.Int J Neuropsychopharmacol2021https://conductscience.org/library/papers/33151310PubMed
30,511,350Revisiting the Concept of Subjective Tolerability to Antipsychotic Medications in Schizophrenia and its Clinical and Research Implications: 30 Years Later.CNS Drugs2019https://conductscience.org/library/papers/30511350PubMed
29,942,132Structural equation modeling approach between salience network dysfunction, depressed mood, and subjective quality of life in schizophrenia: an ICA resting-state fMRI study.Neuropsychiatr Dis Treat2018https://conductscience.org/library/papers/29942132PubMed
22,028,735Suicidal behavior in the older patient with schizophrenia.Aging health2011https://conductscience.org/library/papers/22028735PubMed
21,254,789Managing suicide risk in patients with schizophrenia.CNS Drugs2011https://conductscience.org/library/papers/21254789PubMed
19,011,234Psychiatric comorbidities and schizophrenia.Schizophr Bull2009https://conductscience.org/library/papers/19011234PubMed
18,665,657Co-occurring depressive symptoms in the older patient with schizophrenia.Drugs Aging2008https://conductscience.org/library/papers/18665657PubMed
18,180,760How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials.Mol Psychiatry2009https://conductscience.org/library/papers/18180760PubMed
17,960,353[New insights into the pathogenesis and pathophysiology of depression].Nervenarzt2007https://conductscience.org/library/papers/17960353PubMed
17,284,095Lack of insight in schizophrenia: impact on treatment adherence.CNS Drugs2007https://conductscience.org/library/papers/17284095PubMed
17,139,353The relationships between depression and remission in first-episode psychosis.World Psychiatry2006https://conductscience.org/library/papers/17139353PubMed
16,760,421Does self-perceived mood predict more variance in cognitive performance than clinician-rated symptoms in schizophrenia?Schizophr Bull2006https://conductscience.org/library/papers/16760421PubMed
16,640,124The impact of subjective well-being under neuroleptic treatment on compliance and remission.Dialogues Clin Neurosci2006https://conductscience.org/library/papers/16640124PubMed
16,492,798Subdomains within the negative symptoms of schizophrenia: commentary.Schizophr Bull2006https://conductscience.org/library/papers/16492798PubMed
15,995,904Psychological pathways to depression in schizophrenia: studies in acute psychosis, post psychotic depression and auditory hallucinations.Eur Arch Psychiatry Clin Neurosci2005https://conductscience.org/library/papers/15995904PubMed
15,995,903Antipsychotic and antidepressive effects of second generation antipsychotics: two different pharmacological mechanisms?Eur Arch Psychiatry Clin Neurosci2005https://conductscience.org/library/papers/15995903PubMed
15,812,601Antidepressive effects of traditional and second generation antipsychotics: a review of the clinical data.Eur Arch Psychiatry Clin Neurosci2005https://conductscience.org/library/papers/15812601PubMed

See all 44 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28711

GET https://conductscience.org/api/papers/v1/28711/cited_by?page=2